Stock Report

All about this stock under one free report Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Amneal Pharmaceuticals Inc Class A (AMRX) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$17.43

up-down-arrow $5.25 (43.10%)

As on 04-Sep-2026 13:43EDT

Market cap

info icon

$6,074 Mln

Revenue (TTM)

info icon

$3,118 Mln

P/E Ratio

info icon

36.3

P/B Ratio

info icon

186.5

Div. Yield

info icon

0 %

Edit peer-selector-edit
Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Market cap ($ Mln)
 6,074 14,975 12,310 12,237 10,425
Revenue ($ Mln)
 3,118 692 831 5,020 777
Net Profit ($ Mln)
 157.36 -696.24 54.90 -199.00 -191.64
Net Margin (%)
 5.05 -100.64 6.61 -3.96 -24.68
RoE (%)
 -- -- 8.11 -3.03 -223.36
Price to Earnings
 36.33 -- 264.84 -- --
Price-To-Book
 186.52 123.68 17.91 1.86 129.60

Income Statement ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Operating Revenue arrow
3,117.55 691.84 830.81 5,020.00 776.57
Cost of Revenue arrow
1,891.76 47.45 14.09 2,380.00 52.53
Gross Profit arrow
1,136.09 473.81 748.43 2,050.00 591.02
Operating Expenses arrow
822.55 1,187.86 810.32 2,178.00 912.58
Operating Profit (EBIT) arrow
403.24 -543.47 6.41 462.00 -188.54
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
201.18 -706.17 26.37 -166.00 -191.09
Provision for Tax arrow
-14.14 -7.73 -35.26 33.00 0.56
Profit after Tax (Net Income) arrow
157.36 -696.24 54.90 -199.00 -191.64
Minority Interest arrow
-57.96 6.48 0.00 0.00 0.00
Consolidated Profit arrow
0.00 0.00 0.00 0.00 0.00

Liabilities ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Shareholder's Funds arrow
33.02 -2,515.22 705.78 6,588.00 83.30
Minority Interest arrow
-57.96 6.48 0.00 0.00 0.00
Non-Current Liabilities arrow
2,776.18 2,832.54 29.12 5,121.00 217.70
Current Liabilities arrow
883.19 890.65 153.80 1,852.00 460.45
Total Liabilities arrow
3,678.28 936.03 836.65 13,358.00 689.81

Assets ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Non-Current Assets arrow
1,829.32 124.16 449.03 9,764.00 104.88
Current Assets arrow
1,947.03 1,093.14 439.68 3,797.00 656.57
Total Assets arrow
3,678.28 936.03 836.65 13,358.00 689.81
Total Debt* arrow
2,791.76 2,493.78 9.42 3,918.00 219.21
Net Current Assets arrow
1,063.84 0.00 285.87 1,945.00 0.00

Cashflow ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Cash From Operating Activities arrow
339.99 -445.91 142.00 560.00 -93.41
Cash Flow from Investing Activities arrow
-112.26 -24.49 69.76 -279.00 -0.48
Cash from Financing Activities arrow
-31.53 359.29 -220.37 -275.00 101.47
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
ROCE (%) arrow
2.80 -159.44 14.87 -2.21 -63.21
ROE (%) arrow
-80.04 41.15 8.11 -3.03 -223.36
ROA (%) arrow
3.42 -39.04 5.52 -1.30 -15.97
EBIT Margin (%) arrow
14.69 -89.09 3.17 1.61 -17.57
Net Margin (%) arrow
5.05 -100.64 6.61 -3.96 -24.68
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Revenue Growth (%) arrow
9.28 193.38 16.02 11.95 56.87
EBIT Growth (%) arrow
35.27 5.05 -79.11 -90.61 42.45
Net Profit Growth (%) arrow
4,562.61 10.33 -58.66 -145.85 22.38
EPS Growth (%) arrow
7,441.17 12.58 -62.44 -146.42 25.75
Book Value Growth (%) arrow
128.83 -36.90 12.98 -3.87 9.44

Valuation Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Price / Earnings arrow
56.80 -20.69 41.86 -48.47 -50.48
Price / Book Value arrow
-57.81 -7.27 6.44 1.72 104.73
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
10.79 -25.60 55.67 21.77 -54.53
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Debt to Equity arrow
77.65 0.00 0.00 0.58 0.00
Short term debt to equity ratio arrow
3.68 -0.22 0.00 0.01 0.85
Current Ratio arrow
2.20 1.23 2.86 2.05 1.43
Quick Ratio arrow
1.44 1.17 2.77 1.10 1.34
Interest Coverage arrow
1.88 -6.86 -- 0.36 -37.09

Operating Efficiency Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM)
Debtors to sales (%) arrow
32.74 36.78 9.26 22.95 35.73
Asset Turnover arrow
0.68 0.39 0.84 0.33 0.65
Receivable days arrow
103.79 52.44 28.27 70.73 104.82
Inventory Days arrow
118.22 172.81 355.76 226.89 167.98
Payable days arrow
49.91 296.14 785.55 45.50 529.03
Cash Conversion Cycle arrow
172.10 -70.89 -401.52 252.12 -256.23
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...